| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
| ― | £251.40K | ― | ― | ― | ― | ― | |
76 Outperform | £692.43M | 2.45 | 15.66% | 4.89% | 16.42% | 33.07% | |
69 Neutral | £49.09M | ― | 12.02% | ― | 5.39% | ― | |
50 Neutral | £5.11M | 55.56 | -30.89% | ― | -6.07% | 50.59% | |
42 Neutral | £677.15K | -0.53 | ― | ― | ― | ― |